FI830245L - Foerbaettringar beroerande via naesan intagbara farmaceutiska kompositioner - Google Patents

Foerbaettringar beroerande via naesan intagbara farmaceutiska kompositioner

Info

Publication number
FI830245L
FI830245L FI830245A FI830245A FI830245L FI 830245 L FI830245 L FI 830245L FI 830245 A FI830245 A FI 830245A FI 830245 A FI830245 A FI 830245A FI 830245 L FI830245 L FI 830245L
Authority
FI
Finland
Prior art keywords
composition
medicinal product
pharmaceutical composition
pharmaceutical
medicinal
Prior art date
Application number
FI830245A
Other languages
English (en)
Other versions
FI830245A0 (fi
FI81258B (fi
FI81258C (fi
Inventor
Jean-Rene Kiechel
Francoise Acezat-Mispelter
Danielle Plas
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI830245A0 publication Critical patent/FI830245A0/fi
Publication of FI830245L publication Critical patent/FI830245L/fi
Publication of FI81258B publication Critical patent/FI81258B/fi
Application granted granted Critical
Publication of FI81258C publication Critical patent/FI81258C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI830245A 1982-02-01 1983-01-25 Foerfarande foer framstaellning av en farmaceutisk komposition foer nasal administration. FI81258C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01
GB8202781 1982-02-01

Publications (4)

Publication Number Publication Date
FI830245A0 FI830245A0 (fi) 1983-01-25
FI830245L true FI830245L (fi) 1983-08-02
FI81258B FI81258B (fi) 1990-06-29
FI81258C FI81258C (fi) 1990-10-10

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
FI830245A FI81258C (fi) 1982-02-01 1983-01-25 Foerfarande foer framstaellning av en farmaceutisk komposition foer nasal administration.

Country Status (27)

Country Link
JP (1) JPS58134017A (fi)
AT (1) AT385656B (fi)
AU (1) AU565613B2 (fi)
BE (1) BE895750A (fi)
CA (1) CA1197783A (fi)
CH (1) CH653555A5 (fi)
DE (1) DE3302949A1 (fi)
DK (1) DK164771C (fi)
ES (1) ES519450A0 (fi)
FI (1) FI81258C (fi)
FR (1) FR2539994B1 (fi)
GR (1) GR81320B (fi)
HK (1) HK59989A (fi)
HU (1) HU191512B (fi)
IE (1) IE54532B1 (fi)
IL (1) IL67822A (fi)
IT (1) IT1197558B (fi)
KE (1) KE3888A (fi)
LU (1) LU84613A1 (fi)
MY (1) MY8700766A (fi)
NL (1) NL192325C (fi)
NZ (1) NZ203117A (fi)
PH (1) PH22198A (fi)
PT (1) PT76166B (fi)
SE (1) SE454402B (fi)
SG (1) SG34389G (fi)
ZA (1) ZA83673B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
CN111936140A (zh) * 2018-01-05 2020-11-13 英倍尔药业股份有限公司 通过精密鼻装置的双氢麦角胺的鼻内递送

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
IT8347646A0 (it) 1983-02-01
IL67822A (en) 1988-02-29
JPH0253406B2 (fi) 1990-11-16
AU565613B2 (en) 1987-09-24
ES8502865A1 (es) 1985-02-01
KE3888A (en) 1989-09-01
IT1197558B (it) 1988-12-06
FR2539994B1 (fr) 1986-10-10
NL192325B (nl) 1997-02-03
DK164771B (da) 1992-08-17
CA1197783A (en) 1985-12-10
FI830245A0 (fi) 1983-01-25
IE830187L (en) 1983-08-01
DE3302949A1 (de) 1983-08-11
BE895750A (fr) 1983-08-01
PH22198A (en) 1988-06-28
AU1085083A (en) 1983-08-11
ATA30383A (de) 1987-10-15
SG34389G (en) 1989-09-22
MY8700766A (en) 1987-12-31
SE454402B (sv) 1988-05-02
DK164771C (da) 1992-12-28
PT76166A (en) 1983-02-01
FI81258B (fi) 1990-06-29
NZ203117A (en) 1986-12-05
NL8300325A (nl) 1983-09-01
LU84613A1 (fr) 1983-09-08
JPS58134017A (ja) 1983-08-10
DK38183D0 (da) 1983-01-31
CH653555A5 (de) 1986-01-15
DE3302949C2 (fi) 1992-05-21
AT385656B (de) 1988-05-10
NL192325C (nl) 1997-06-04
DK38183A (da) 1983-08-02
SE8300495L (sv) 1983-08-02
FR2539994A1 (fr) 1984-08-03
SE8300495D0 (sv) 1983-01-31
ZA83673B (en) 1984-09-26
GR81320B (fi) 1984-12-11
FI81258C (fi) 1990-10-10
IE54532B1 (en) 1989-11-08
PT76166B (en) 1986-02-04
HU191512B (en) 1987-02-27
HK59989A (en) 1989-08-04
ES519450A0 (es) 1985-02-01
IL67822A0 (en) 1983-06-15

Similar Documents

Publication Publication Date Title
IT8023228A0 (it) Composizione farmaceutica a cessione prolungata contenente un medicamento solido e procedimento per la sua preparazione.
DK68392D0 (da) Farmaceutisk praeparat indeholdende cefuroximaxetil
DK82982A (da) Bandage til indgift af et gavnligt laegemiddel
FR2636527B1 (fr) Capsule pour medicaments
FI892640A0 (fi) Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi
JPS567714A (en) Pharmaceutical medicine
DK247581A (da) Inhaleringsapparat til pulveriserede laegemidler
DK163959C (da) Farmaceutisk praeparat til oral indgift indeholdende cimetidin
PT86986A (pt) Substituted 9-amino-tetrahydroacridines and related compounds a process for their preparation and their use as medicaments
FR2341307A1 (fr) Pyrethrinoides a titre de medicaments et compositions pharmaceutiques les renfermant
JPS55147223A (en) Pharmaceutical medicine
DK272383D0 (da) Farmaceutisk blandingspraeparat
BE894376A (fr) Preparation pharmaceutique
IT1193552B (it) Dispositivo per la somministrazione di medicinali a ruminanti
IT8147821A0 (it) Di sostanze medicamentose dispositivo per la somministrazione
DK173081A (da) Farmaceutisk produkt til oral administration indeholdende cytidindiphosphocholin
PT88682A (pt) A process for the preparation of pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
PT88681A (pt) A process for the preparation of pharmaceutical compositions containing piperidinoalkanol derivatives
JPS57114508A (en) Pharmaceutical medicine for use of choline- action suppressive drug
PT87679A (pt) A process for the preparation of 2-methoxymethyl-penem derivatives and of pharmaceutical compositions containing the same
FI810934L (fi) Farmaceutiska produkter
FI830245L (fi) Foerbaettringar beroerande via naesan intagbara farmaceutiska kompositioner
FI832426L (fi) Farmaceutiska kompositioner innehaollande meptazinol och ibuprofen
FI803846L (fi) Farmaceutiska produkter
ES529819A0 (es) Medicamento que contiene muzolimina

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MA Patent expired

Owner name: NOVARTIS AG